Autopsy report · NCT05640115

Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent

“Study stopped due to lack of accrual”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

University of Chicago

Sponsor type

University, hospital or other

Conditions

Cancer; Urinary Obstruction; Malignancy; Urinary Dysfunction; Ureter Obstruction; Ureter Injury

Interventions

Ureteral Stent; Percutaneous Nephrostomy Tube Placement

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
  “Study was halted for lack of accrual” (96% match in meaning)
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
  “Study stopped due to low accrual.” (94% match in meaning)
• Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer
  “Study was terminated due to lack of accrual” (89% match in meaning)
• Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer
  “Study was terminated due to poor accrual” (87% match in meaning)
• Sorafenib-induced Hand- Foot Skin Reaction Treatment
  “Study was halted due to poor subject accrual.” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.